CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study.

Clicks: 437
ID: 58603
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #4 of 31 articles by views in Anticancer research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Oropharyngeal mucositis occurs in virtually all patients with head and neck cancer receiving radiochemotherapy. The manipulation of the oral cavity microbiota represents an intriguing and challenging target.A total of 75 patients were enrolled to receive Lactobacillus brevis CD2 lozenges or oral care regimen with sodium bicarbonate mouthwashes. The primary endpoint was the incidence of grade 3 or 4 oropharyngeal mucositis during radiotherapy treatment.There was no statistical difference in the incidence of grade 3-4 oropharyngeal mucositis between the intervention and control groups (40.6% vs. 41.6% respectively, p=0.974). The incidence of pain, dysphagia, body weight loss and quality of life were not different between the experimental and standard arm.Our study was not able to demonstrate the efficacy of L. brevis CD2 lozenges in preventing radiation-induced mucositis in patients with head and neck cancer. Although modulating homeostasis of the salivary microbiota in the oral cavity seems attractive, it clearly needs further study.
Reference Key
de-sanctis2019anticancer Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors DE Sanctis, Vitaliana;Belgioia, Liliana;Cante, Domenico;LA Porta, Maria R;Caspiani, Orietta;Guarnaccia, Roberta;Argenone, Angela;Muto, Paolo;Musio, Daniela;DE Felice, Francesca;Maurizi, Francesca;Bunkhelia, Feisal;Ruo Redda, Maria Grazia;Reali, Alessia;Valeriani, Maurizio;Osti, Mattia F;Alterio, Daniela;Bacigalupo, Almalina;Russi, Elvio G;
Journal Anticancer research
Year 2019
DOI
10.21873/anticanres.13303
URL
Keywords
imrt mucositis lactobacillus brevis cd2 head neck cancer radiobiotherapy radiochemotherapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.